C12Y 204/01025
4-alpha-glucanotransferase
Official title: 4-Alpha-glucanotransferase (2.4.1.25)
C12Y204/01025 (4-alpha-glucanotransferase) appears on 24 US grants and 36 published applications in this corpus.
Search patents in C12Y- Granted patents
- 24
- Published applications
- 36
- Assignees
- 30
- Inventors
- 72
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 1 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 2 | 3 |
| 2011 | 1 | 1 |
| 2012 | 1 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 2 |
| 2017 | 0 | 0 |
| 2018 | 1 | 3 |
| 2019 | 0 | 3 |
| 2020 | 3 | 1 |
| 2021 | 1 | 6 |
| 2022 | 2 | 4 |
| 2023 | 2 | 2 |
| 2024 | 1 | 3 |
| 2025 | 2 | 0 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Therapeutics for glycogen storage disease type iii11 Aug 2026US 12,703,858 B2Ultragenyx Pharmaceutical Inc.
- Mini-GDE for the treatment of glycogen storage disease III26 May 2026US 12,637,668 B2Association Institut De Myologie
- Methods for modifying high intensity sweetener glycosides4 Feb 2025US 12,213,501 B2Optibiotix Limited
- Enzymatic production of hexoses4 Feb 2025US 12,215,371 B2Bonumose, Inc.
- Compositions and methods comprising the use of Exiguobacterium acetylicum and Bacillus coagluans α-glucanotransferase enzymes30 Jan 2024US 11,884,942 B2Dupont Nutrition Biosciences Aps
- Mini-gde for the treatment of glycogen storage disease iii10 Sep 2026US 2026/0265720 A1Association Institut De Myologie
- N-terminal truncated gde for the treatment of glycogen storage disease iii20 Aug 2026US 2026/0242762 A1Genethon
- Hybrid aav vector enhancing transgene expression in the liver21 May 2026US 2026/0139270 A1Genethon
- Method for the enzymatic production of soluble fibres7 May 2026US 2026/0125726 A1Roquette Freres
- Compositions of dna molecules encoding amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase, methods of making thereof, and methods of use thereof31 Oct 2024US 2024/0358852 A1Anjarium Biosciences AG
Most cited
By later US patents
- Polypeptides having glucanotransferase activity and nucleic acids encoding same12US 6,617,143 B1Novozymes A/S · 2003
- Thermo-irreversible gel particles for use in foods11US 5,294,457 ARhone-Poulenc Inc. · 1994
- Dietary fiber compositions for use in foods10US 5,380,542 ARhone-Poulenc Specialties Chemical Co. · 1995
- Dietary fiber compositions for use in comminuted meats7US 5,294,456 ARhone-Poulenc Inc. · 1994
- Messenger UNA molecules and uses thereof5US 10,815,463 B2Arcturus Therapeutics, Inc. · 2020